Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma

Christian Karime, Jing Wang, Gregory Woodhead, Kabir Mody, Charles T. Hennemeyer, Mitesh J. Borad, Daruka Mahadevan, Sreenivasa R. Chandana, Hani Babiker

Producción científica: Article › revisión exhaustiva

8 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma'. En conjunto forman una huella única.

Pharmacology, Toxicology and Pharmaceutical Science